Cardiol Therapeutics Inc. (CRDL) Financials
CRDL Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 22.6 million | 5.2 million |
| Dec. 31, 2025 | 17.2 million | 4.2 million |
| Sept. 30, 2025 | 9.3 million | 2.4 million |
| June 30, 2025 | 14.7 million | 6.0 million |
CRDL Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -5.4 million | 1.3 million |
| Dec. 31, 2025 | -3.8 million | 2.2 million |
| Sept. 30, 2025 | -5.0 million | 2.9 million |
| June 30, 2025 | -3.3 million | 1.9 million |
CRDL Net Income
No data available :(
CRDL Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 19.9 million | - | 55083 |
| Dec. 31, 2025 | 15.6 million | - | 91556 |
| Sept. 30, 2025 | 8.3 million | - | 96378 |
| June 30, 2025 | 13.4 million | - | 104770 |
CRDL Shares Outstanding
CRDL Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 34214 | 3.6 million | 3.4 million | - |
| Dec. 31, 2025 | 2252 | 2.0 million | 3.8 million | - |
| Sept. 30, 2025 | 2167 | 3.4 million | 3.9 million | - |
| June 30, 2025 | 4732 | 2.0 million | 3.6 million | - |
CRDL Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 19202 |
| Dec. 31, 2025 | - | 18930 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | - |
CRDL
Price: $1.28
52 week price:
Earnings Per Share: -0.28 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 88200
Market Capitalization: 123.3 million